AHC Group Inc. (TYO:7083)
971.00
+5.00 (0.52%)
May 20, 2025, 2:19 PM JST
AHC Group Revenue
AHC Group had revenue of 1.57B JPY in the quarter ending February 28, 2025, with 4.26% growth. This brings the company's revenue in the last twelve months to 6.33B, up 4.49% year-over-year. In the fiscal year ending November 30, 2024, AHC Group had annual revenue of 6.27B with 5.97% growth.
Revenue (ttm)
6.33B
Revenue Growth
+4.49%
P/S Ratio
0.32
Revenue / Employee
13.47M
Employees
470
Market Cap
2.03B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Nov 30, 2024 | 6.27B | 353.00M | 5.97% |
Nov 30, 2023 | 5.92B | 1.01B | 20.62% |
Nov 30, 2022 | 4.90B | 790.00M | 19.20% |
Nov 30, 2021 | 4.11B | 28.00M | 0.69% |
Nov 30, 2020 | 4.09B | -34.00M | -0.83% |
Nov 30, 2019 | Pro | Pro | Pro |
Nov 30, 2018 | Pro | Pro | Pro |
Nov 30, 2017 | Pro | Pro | Pro |
Nov 30, 2016 | Pro | Pro | Pro |
Nov 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,222.12B |
Daiichi Sankyo Company | 1,886.26B |
Takeda Pharmaceutical Company | 4,581.55B |
HOYA Corporation | 869.37B |
Terumo | 1,036.17B |
Otsuka Holdings | 2,393.18B |
Astellas Pharma | 1,912.32B |
Olympus | 997.33B |